Biological Psychiatry logo Elsevier logo

Publisher: Elsevier

Related content
Volume 45, Number 9, May 1999

< previous issue | all issues | next issue >

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression*
pp. 1085-1098(14)
Authors: Rajkowska G.; Miguel-Hidalgo J.J.; Wei J.; Dilley G.; Pittman S.D.; Meltzer H.Y.; Overholser J.C.; Roth B.L.; Stockmeier C.A.

MRI anatomy of schizophrenia - A magnetic resonance imaging study
pp. 1099-1119(21)
Authors: McCarley R.W.; Wible C.G.; Frumin M.; Hirayasu Y.; Levitt J.J.; Fischer I.A.; Shenton M.E.

The size and fiber composition of the anterior commissure with respect to gender and schizophrenia
pp. 1120-1127(8)
Authors: Highley J.R.; Esiri M.M.; McDonald B.; Roberts H.C.; Walker M.A.; Crow T.J.

Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI
pp. 1128-1137(10)
Authors: Manoach D.S.; Press D.Z.; Thangaraj V.; Searl M.M.; Goff D.C.; Halpern E.; Saper C.B.; Warach S.

Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: a pilot study
pp. 1138-1142(5)
Authors: Warner R.; Laugharne J.; Peet M.; Brown L.; Rogers N.

Genetic antecedents of dopamine dysfunction in schizophrenia
pp. 1143-1150(8)
Authors: Amin F.; Silverman J.M.; Siever L.J.; Smith C.J.; Knott P.J.; Davis K.L.

Modulation of the firing activity of rat serotonin and noradrenaline neurons by (+/-)pindolol
pp. 1163-1169(7)
Authors: Haddjeri N.; de Montigny C.; Blier P.

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial
pp. 1170-1177(8)
Authors: Berman R.M.; Anand A.; Cappiello A.; Miller H.L.; Hu X.S.; Oren D.A.; Charney D.S.

Effects of myo-Inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study
pp. 1197-1202(6)
Authors: Moore C.M.; Breeze J.L.; Kukes T.J.; Rose S.L.; Dager S.R.; Cohen B.M.; Renshaw P.F.

Cytokines in detoxified patients with chronic alcoholism without liver disease: increased monocytic cytokine production
pp. 1212-1216(5)
Authors: Song C.; Lin A.; De Jong R.; Vandoolaeghe E.; Kenis G.; Bosmans E.; Whelan A.; Scharpe S.; Maes M.

Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study
pp. 1221-1225(5)
Authors: Volz H.-P.; Roszger G.; Riehemann S.; Hubner G.; Maurer I.; Wenda B.; Rzanny R.; Kaiser W.A.; Sauer H.

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder
pp. 1226-1229(4)
Authors: Hertzberg M.A.; Butterfield M.I.; Feldman M.E.; Beckham J.C.; Sutherland S.M.; Connor K.M.; Davidson J.R.T.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page